The company’s revenues increased 19 percent, ahead of Zacks Consensus estimate. Zacks maintains a neutral rating for AmSurg stock.
At the end of December 2012, the company operated 250 ASCs. Of AmSurg’s centers, 149 perform GI procedures, 48 are multispecialty centers, 36 perform ophthalmology procedures and seven perform orthopedic procedures.
More Articles on Transactions and Valuation Issues:
13 Ambulatory Surgery Center Openings, Plans & Expansions
9 Statistics on Surgery Center Liquidity Based on Case Volume
ASC Sector M&A Activity: Outlook for 2014
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
